| For: | Norton PA, Mehta AS. Expression of genes that control core fucosylation in hepatocellular carcinoma: Systematic review. World J Gastroenterol 2019; 25(23): 2947-2960 [PMID: 31249452 DOI: 10.3748/wjg.v25.i23.2947] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i23/2947.htm |
| Number | Citing Articles |
| 1 |
|
| 2 |
Qiu Pan, Yan Xie, Ying Zhang, Xinqi Guo, Jing Wang, Min Liu, Xiao-Lian Zhang. EGFR core fucosylation, induced by hepatitis C virus, promotes TRIM40-mediated-RIG-I ubiquitination and suppresses interferon-I antiviral defenses. Nature Communications 2024; 15(1) doi: 10.1038/s41467-024-44960-6
|
| 3 |
Mingchen Xie, Fuxu Wang, Bing Chen, Zeyu Wu, Ci Chen, Jian Xu. Systematic pan-cancer analysis identifies SLC35C1 as an immunological and prognostic biomarker. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-32375-0
|
| 4 |
Nicholas J. G. Webster, Deepak Kumar, Panyisha Wu. Dysregulation of RNA splicing in early non-alcoholic fatty liver disease through hepatocellular carcinoma. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-52237-7
|
| 5 |
Joseph C. Gonzalez, Saborni Chakraborty, Natalie K. Thulin, Taia T. Wang. Heterogeneity in IgG‐CD16 signaling in infectious disease outcomes*. Immunological Reviews 2022; 309(1) doi: 10.1111/imr.13109
|
| 6 |
Jia Yin, Xuan Yin, Lei Tao, Yuanzhi Peng, Shuhan Zhao, Haifeng Hou, Xinyue Yin, Zhangshen Ran, Aihong Zhou, Guoyong Ding. Association between immunoglobulin G N-glycosylation, inflammatory factors, and ankylosing spondylitis: A case–control study. Clinical Rheumatology 2025; 44(11) doi: 10.1007/s10067-025-07639-x
|
| 7 |
秋芊 罗. Study on the Role of SLC35E4 Gene in Proliferation, Migration, and Apoptosis of Human Intrahepatic Cholangiocarcinoma Cells. World Journal of Cancer Research 2025; 15(04) doi: 10.12677/wjcr.2025.154023
|
| 8 |
Nian-Zhu Zhang, Li-Fen Zhao, Qian Zhang, Hui Fang, Wan-Li Song, Wen-Zhe Li, Yu-Song Ge, Peng Gao. Core fucosylation and its roles in gastrointestinal glycoimmunology. World Journal of Gastrointestinal Oncology 2023; 15(7): 1119-1134 doi: 10.4251/wjgo.v15.i7.1119
Abstract(841) |
Core Tip(953) |
Full Article(HTML)(5671)
|
Full Article (PDF)-2199K(389)
|
Full Article with Cover (PDF)-2409K(252)
|
Full Article (Word)-972K(57)
|
Full Article (XML)-279K(182)
|
Audio-2509K(18)
|
Peer-Review Report-269K(176)
|
Answering Reviewers-63K(199)
|
Times Cited (16)
|
Total Visits (7868)
|
Open
|
| 9 |
Caixia Liang, Wanli Song, Jianguo Gu. Glycosignals in Cancer. 2023; doi: 10.1007/978-981-19-7732-9_6
|
| 10 |
Ayana Kishibuchi, Azusa Sakamoto, Takaki Sakurai, Hiroyuki Marusawa. AFP-producing gastric cancer and hepatocellular carcinoma with discrepancies in AFP-L3 expression. Clinical Journal of Gastroenterology 2026; 19(4) doi: 10.1007/s12328-026-02340-1
|
| 11 |
Jamal Manoochehri, Neda Kamal, Hossein Jafari Khamirani, Sina Zoghi, Maryam Fazelzadeh Haghighi, Hamed Reza Goodarzi, Seyed Mohammad Bagher Tabei. A combination of two novels homozygous FCSK variants cause disorder of glycosylation with defective fucosylation: New patient and literature review. European Journal of Medical Genetics 2022; 65(8) doi: 10.1016/j.ejmg.2022.104535
|
| 12 |
Roberto De Masi, Stefania Orlando. GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review. International Journal of Molecular Sciences 2022; 23(13) doi: 10.3390/ijms23137373
|
| 13 |
Caihan Duan, Junhao Wu, Zhe Wang, Xiaohua Hou, Chaoqun Han. Fucosylation in digestive inflammatory diseases and cancers: From mechanical studies to clinical translation. Genes & Diseases 2025; 12(6) doi: 10.1016/j.gendis.2025.101570
|
| 14 |
Yuki Ohkawa, Yoichiro Harada, Naoyuki Taniguchi. Keratan sulfate-based glycomimetics using Langerin as a target for COPD: lessons from studies on Fut8 and core fucose. Biochemical Society Transactions 2021; 49(1) doi: 10.1042/BST20200780
|
| 15 |
Mikel García-Alija, Berre van Moer, Diego E. Sastre, Tala Azzam, Jonathan J. Du, Beatriz Trastoy, Nico Callewaert, Eric J. Sundberg, Marcelo E. Guerin. Modulating antibody effector functions by Fc glycoengineering. Biotechnology Advances 2023; 67 doi: 10.1016/j.biotechadv.2023.108201
|
| 16 |
Emma Butaye, Nicky Somers, Lorenz Grossar, Nele Pauwels, Sander Lefere, Lindsey Devisscher, Sarah Raevens, Anja Geerts, Leander Meuris, Nico Callewaert, Hans Van Vlierberghe, Xavier Verhelst. Systematic review: Glycomics as diagnostic markers for hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics 2024; 59(1) doi: 10.1111/apt.17748
|
| 17 |
Zhenzhen Liu, Zhentao Liu, Xin Zhou, Yongqu Lu, Yanhong Yao, Wendong Wang, Siyi Lu, Bingyan Wang, Fei Li, Wei Fu. A glycolysis-related two-gene risk model that can effectively predict the prognosis of patients with rectal cancer. Human Genomics 2022; 16(1) doi: 10.1186/s40246-022-00377-0
|
| 18 |
Mahdokht Kohansal-Nodehi, Magdalena Swiatek-de Lange, Konstantin Kroeniger, Vinzent Rolny, Glòria Tabarés, Teerha Piratvisuth, Tawesak Tanwandee, Satawat Thongsawat, Wattana Sukeepaisarnjaroen, Juan Ignacio Esteban, Marta Bes, Bruno Köhler, Henry Lik-Yuen Chan, Holger Busskamp. Discovery of a haptoglobin glycopeptides biomarker panel for early diagnosis of hepatocellular carcinoma. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1213898
|
| 19 |
Tanja Kunej. Rise of Systems Glycobiology and Personalized Glycomedicine: Why and How to Integrate Glycomics with Multiomics Science?. OMICS: A Journal of Integrative Biology 2019; 23(12) doi: 10.1089/omi.2019.0149
|
| 20 |
Naoyuki Taniguchi, Yuki Ohkawa, Kento Maeda, Yoichiro Harada, Masamichi Nagae, Yasuhiko Kizuka, Hideyuki Ihara, Yoshitaka Ikeda. True significance of N-acetylglucosaminyltransferases GnT-III, V and α1,6 fucosyltransferase in epithelial-mesenchymal transition and cancer. Molecular Aspects of Medicine 2021; 79 doi: 10.1016/j.mam.2020.100905
|
| 21 |
Kayla Bastian, Emma Scott, David J. Elliott, Jennifer Munkley. FUT8 Alpha-(1,6)-Fucosyltransferase in Cancer. International Journal of Molecular Sciences 2021; 22(1) doi: 10.3390/ijms22010455
|
| 22 |
Andrew T. DelaCourt, Anand S. Mehta. Comprehensive Pharmacology. 2022; doi: 10.1016/B978-0-12-820472-6.00007-4
|
| 23 |
Kyle A. Starost, Jagadeeswara R. Bommi, Prasenjit Mitra, Seth J. Field. The Golgi Network, Volume II. Subcellular Biochemistry 2026; 111 doi: 10.1007/978-3-032-16833-7_15
|
| 24 |
Andrew DelaCourt, Anand Mehta. Novel Methods and Pathways in Cancer Glycobiology Research. Advances in Cancer Research 2023; 157 doi: 10.1016/bs.acr.2022.07.002
|
| 25 |
Ayesha Rahman, Lingadahalli S. Shashidhara. Analyzing the influence of IL18 in regulation of YAP1 in breast oncogenesis using cBioportal. Cancer Reports 2022; 5(3) doi: 10.1002/cnr2.1484
|
| 26 |
Gabriele Antonarelli, Valentina Pieri, Francesca Maria Porta, Nicola Fusco, Gaetano Finocchiaro, Giuseppe Curigliano, Carmen Criscitiello. Targeting Post-Translational Modifications to Improve Combinatorial Therapies in Breast Cancer: The Role of Fucosylation. Cells 2023; 12(6) doi: 10.3390/cells12060840
|